2F5A | date | |
|||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
authors | |||||||||||||||
compound | source | ||||||||||||||
symmetry |
| ||||||||||||||
crystal cell |
| ||||||||||||||
method | X-Ray Diffraction | resolution | |||||||||||||
related structures | by homologous chain: 1QP1, 1REI, 1TJH, 1U8I | ||||||||||||||
Primary reference | Crystallographic definition of the epitope promiscuity of the broadly neutralizing anti-human immunodeficiency virus type 1 antibody 2F5: vaccine design implications., Bryson S, Julien JP, Hynes RC, Pai EF, J Virol. 2009 Nov;83(22):11862-75. Epub 2009 Sep 9. PMID:19740978 |
Data retrieval |
View 2F5A in 3D |
Structure-derived information |
Sequence-derived information |
OCA© by Jaime Prilusky, 1996-2014,2022,2024 Bioinformatics Unit Weizmann Institute of Science |